×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
Yahoo Finance
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
5 days ago
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
5 days ago
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Defense World
Read Allspring Global Investments Holdings LLC Decreases Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) at Defense World.
2 days ago
With trial win for oral thalassemia drug, Agios charts broader path than gene therapy rivals
Fierce Pharma
Gene therapies have been approved for certain patients with beta thalassemia. After a successful phase 3 readout, Agios hopes it can reach a...
3 months ago
Agios' Pyrukynd coming from behind with new uses?
BioWorld MedTech
Agios Pharmaceuticals Inc.'s fourth-quarter and full-year 2023 financial report in mid-February highlighted further prospects with Pyrukynd...
1 week ago
Agios's mitapivat meets endpoints in Phase III thalassemia trial
Clinical Trials Arena
Agios Pharmaceuticals's mitapivat met primary and two key secondary endpoints in a Phase III ENERGIZE trial in patients with non-transfusion-...
3 months ago
Agios Aces Phase III Study in Adults with Alpha- or Beta-Thalassemia
BioSpace
Agios Pharmaceuticals met the primary endpoint in a late-stage trial investigating its drug mitapivat in treating adults with...
3 months ago
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
Investor's Business Daily
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark ... Agios Pharmaceuticals (AGIO) had its Relative Strength (RS) Rating...
2 months ago
Agios Pharma’s stock soars 19.6% on news of positive results in trial of treatment for rare blood disorder
MarketWatch
Agios Pharmaceuticals Inc.'s stock soared 19.6% early Wednesday, after the biotech announced positive results from a Phase 3 trial of a...
3 months ago
Agios Pharmaceuticals (AGIO) Scheduled to Post Quarterly Earnings on Thursday
MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) will be releasing earnings before the market opens on Thursday, May 2, Zacks reports.
5 days ago